cinacalcet has been researched along with Infant, Newborn, Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Demir, S; Dilek, E; Gürkan, H; İnan, M; Kökenli, F; Özgüç Çömlek, F; Sezer, A | 1 |
| Ata, P; Bereket, A; Bilgen, H; Eltan, M; Gulcan-Kersin, S; Kirkgoz, T; Ozek, E; Rzayev, T; Turan, S | 1 |
| Accadia, M; Capozza, M; Chinellato, I; Di Lorgi, N; Di Mauro, A; Guarnieri, V; Laforgia, N; Mattioli, G; Traggiai, C | 1 |
| Huang, L; Sun, X; Tao, Y; Wu, J; Yang, F | 1 |
| Domínguez Quintero, ML; Ferrer Castillo, MT; García Soblechero, E; González Fuentes, C; Jiménez Crespo, B | 1 |
| Gannon, AW; Levine, MA; Monk, HM | 1 |
| Abali, S; Altuncu, E; Atay, Z; Bereket, A; Canaff, L; Cole, DE; Haliloglu, B; Hendy, GN; Ozdogan, T; Turan, S; Vilaça, T; Wong, BY | 1 |
2 review(s) available for cinacalcet and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Novel homozygous inactivating mutation of the calcium-sensing receptor gene in neonatal severe hyperparathyroidism responding to cinacalcet therapy: A case report and literature review.
Topics: Calcimimetic Agents; Calcium; Cinacalcet; Female; Genetic Testing; Homozygote; Humans; Hyperparathyroidism, Primary; Infant; Infant, Newborn; Infant, Newborn, Diseases; Mutation; Parathyroid Hormone; Receptors, Calcium-Sensing | 2018 |
Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review.
Topics: Cinacalcet; Humans; Hyperparathyroidism; Infant, Newborn; Infant, Newborn, Diseases; Male; Naphthalenes; Receptors, Calcium-Sensing; Severity of Illness Index; Treatment Outcome | 2014 |
5 other study(ies) available for cinacalcet and Infant, Newborn, Diseases
| Article | Year |
|---|---|
The efficiency of cinacalcet treatment in delaying parathyroidectomy in a case with neonatal severe hyperparathyroidism caused by homozygous mutation in the CASR gene.
Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Male; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing | 2022 |
Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation.
Topics: Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Receptors, Calcium-Sensing | 2020 |
Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
Topics: Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Clodronic Acid; Diphosphonates; Female; Fluid Therapy; Furosemide; Genes, Recessive; Homozygote; Humans; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing | 2018 |
Neonatal hypercalcemia due to a homozygous mutation in the calcium-sensing receptor: failure of cinacalcet.
Topics: Calcimimetic Agents; Cinacalcet; DNA Mutational Analysis; Drug Resistance; Exons; Genetic Predisposition to Disease; Homozygote; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Male; Naphthalenes; Phenotype; Receptors, Calcium-Sensing; Sequence Deletion; Treatment Failure | 2013 |
Novel homozygous inactivating mutation of the calcium-sensing receptor gene (CASR) in neonatal severe hyperparathyroidism-lack of effect of cinacalcet.
Topics: Cinacalcet; Female; Homozygote; Humans; Hyperparathyroidism; Infant, Newborn; Infant, Newborn, Diseases; Male; Mutation; Naphthalenes; Pedigree; Receptors, Calcium-Sensing | 2014 |